Uncategorized pages

From OncoWiki
Jump to: navigation, search

Showing below up to 328 results in range #1 to #328.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. 5-FU + Cisplatin
  2. 5-FU + Cisplatin + Docetaxel
  3. 5-FU + Cisplatin + RT
  4. 5-FU + Cisplatin + RT + Surgery
  5. 5-FU + Cisplatin + Vinblastine + RT + Surgery
  6. 5-FU + LV
  7. 5-FU + LV + Bevacizumab
  8. 5-FU + LV + Irinotecan
  9. 5-FU + LV + Mitomycin + Dipyridamole
  10. 5-FU + LV + RT
  11. 5-FU + RT
  12. 5-FU MitomycinC Radiation Therapy EORTC Regimen
  13. 5-FU MitomycinC Radiation Therapy Wayne State Regimen
  14. A-C-T
  15. ABDIC
  16. ABVD
  17. AC
  18. AD
  19. ADE
  20. ADOC
  21. AI
  22. AIDA-PETHEMA Group
  23. APL4 - ALLG
  24. ASHAP
  25. ATRA plus As203
  26. Acute Lymphoblastic Leukemia, Adult
  27. Acute Lymphoblastic Leukemia, Pediatric
  28. Acute Myeloid Leukemia,Adult
  29. Adrenocortical Carcinoma
  30. Adriamycin + Cisplatin
  31. Adriamycin + Cisplatin + Paclitaxel
  32. Alemtuzumab + Fludarabine
  33. Amrubicin
  34. Anal Carcinoma
  35. Arsenic Trioxide for APML, new cases
  36. Arsenic Trioxide for relapsed APML
  37. BEAC
  38. BEAM
  39. BEP
  40. BFM- 95 (German Protocol)
  41. BFM B-Cell
  42. BeGeV
  43. Bendamustine
  44. Bendamustine + Rituximab
  45. Bevacizumab
  46. Bevacizumab + Erlotinib
  47. Bevacizumab + IFN
  48. BiRD
  49. Bicalutamide
  50. Bile Duct Cancer Extrahepatic
  51. Bladder Cancer
  52. Bonn protocol
  53. Brain Tumors Adult
  54. Breast Cancer
  55. Brentuximab vedotin
  56. CAF
  57. CALGB 8811
  58. CALGB 9111
  59. CALGB 9710
  60. CB
  61. CBI
  62. CEOP
  63. CEP
  64. CFAR
  65. CHOEP-14
  66. CHOP
  67. CHOP-14
  68. CIM
  69. CLAG
  70. CLAG-M
  71. CMF
  72. CMV
  73. CNOP
  74. CODOX-M/IVAC
  75. COPP
  76. CVD
  77. CVD + IL-2 + IFN
  78. CVP
  79. Cancer treatment information
  80. CapIri
  81. Capecitabine + RT
  82. Carboplatin
  83. Carboplatin + Docetaxel
  84. Carboplatin + Etoposide
  85. Carboplatin + Gemcitabine
  86. Carboplatin + Irinotecan
  87. Carboplatin + Paclitaxel
  88. Carboplatin + Paclitaxel + Bevacizumab
  89. Carboplatin + Paclitaxel + Etoposide
  90. Carboplatin + Pemetrexed
  91. Carboplatin + Vinorelbine
  92. Carcinoid Tumors, Gastrointestinal
  93. Cervical Cancer
  94. Cetuximab
  95. Cetuximab + Irinotecan
  96. ChlVPP
  97. Chlorambucil + Prednisone
  98. Chronic Lymphocytic Leukemia
  99. Chronic Myelogenous Leukemia
  100. Cisplatin
  101. Cisplatin + 5-FU
  102. Cisplatin + 5-FU + RT
  103. Cisplatin + Capecitabine
  104. Cisplatin + Docetaxel
  105. Cisplatin + Epirubicin
  106. Cisplatin + Epirubicin + 5-FU
  107. Cisplatin + Etoposide
  108. Cisplatin + Etoposide + Bleomycin
  109. Cisplatin + Etoposide + RT
  110. Cisplatin + Etoposide + RT → Docetaxel
  111. Cisplatin + Etoposide or Vinorelbine or Vinblastine or Vindesine
  112. Cisplatin + Gemcitabine
  113. Cisplatin + Gemcitabine + Bevacizumab
  114. Cisplatin + Irinotecan
  115. Cisplatin + Irinotecan + Bevacizumab
  116. Cisplatin + Paclitaxel
  117. Cisplatin + Pemetrexed
  118. Cisplatin + RT
  119. Cisplatin + Topotecan
  120. Cisplatin + Vinorelbine
  121. Clofarabine, cyclophosphamide and etoposide
  122. Colon Cancer
  123. Current events
  124. Cyclophosphamide Bortezomib Dexamethasone
  125. Cytarabine Idarubicin Vorinostat consolidation
  126. Cytarabine Idarubicin Vorinostat induction
  127. Cytotoxic Regimens
  128. DAT
  129. DHAP
  130. DHAX
  131. DT-PACE
  132. DVD
  133. Dacarbazine
  134. Dacarbazine + Cisplatin + Carmustine
  135. Dactinomycin
  136. Dasatinib
  137. DaunoXome
  138. Dexa-BEAM
  139. Dexamethasone
  140. Dexamethosone
  141. Docetaxel + Estramustine
  142. Docetaxel + Prednisone
  143. Doxorubicin
  144. Doxorubicin + Bleomycin + Vinblastine
  145. EAPLG
  146. EBVMm
  147. ECF
  148. ECF + surgery + ECF
  149. EP
  150. EPIC
  151. EPOCH
  152. EPOCH-DA
  153. ESHAP
  154. EVA
  155. EVAP
  156. Endometrial Cancer
  157. Erlotinib
  158. Escalated BEACOPP
  159. Esophageal Cancer
  160. Etoposide
  161. Etoposide + Cisplatin
  162. Ewing’s sarcoma and primitive neuroectodermal tumor of bone
  163. FC
  164. FCM
  165. FCR
  166. FLAG
  167. FLAG-Ida
  168. FLOFOXIRI
  169. FLOX
  170. FN
  171. FND
  172. FOLFIRINOX
  173. FOLFIRI + Bevacizumab
  174. FOLFIRI + Cetuximab
  175. FOLFOX
  176. FOLFOX4
  177. FOLFOX4 + Bevacizumab
  178. FOLFOX4 + Cetuximab
  179. FOLFOX6
  180. FOLFOX6 + Bevacizumab
  181. FP + Surgery +/- FP
  182. FUFOX + Cetuximab
  183. Flu Bu ATG - Slavin
  184. Flu Bu ATG for Haplo
  185. Fludarabine + Prednisone
  186. Fludarabine + Rituximab
  187. Flutamide
  188. Fotemustine
  189. GEM-P
  190. GEM-Vinorelbine-Pred
  191. GVD
  192. Gastric Cancer
  193. Gefitinib
  194. Gemcitabine + 5-FU + RT
  195. Gemcitabine + Capecitabine
  196. Gemcitabine + Cisplatin
  197. Gemcitabine + Cisplatin + Paclitaxel
  198. Gemcitabine + Docetaxel
  199. Gemcitabine + Erlotinib
  200. Gemcitabine + Oxaliplatin
  201. Gemcitabine + Paclitaxel
  202. Gemcitabine + Vinorelbine
  203. Gemtuzumab Ozogamicin
  204. Goserelin
  205. Goserelin + Flutamide + RT
  206. Guidelines for contributors
  207. Guidelines on using this site
  208. HAM
  209. Hairy Cell Leukemia
  210. Hematological Malignancies
  211. Hepatocellular Cancer Adult, Primary
  212. High dose Methotrexate
  213. HyperCVAD
  214. HyperCVADHDMTX-AraC
  215. ICE
  216. ICE-aml
  217. IFL + Bevacizumab
  218. IL-2
  219. IMVP-16
  220. IVE
  221. Ifosfamide
  222. Ifosfamide + Paclitaxel
  223. Kaposi's Sarcoma
  224. Ketoconazole
  225. Kidney Renal Cell Cancer
  226. LALA
  227. LV5FU-P
  228. LV + 5-FU + Irinotecan + Bevacizumab
  229. Lenalidomide + Rituximab
  230. Linker Regimen
  231. Lung Cancer Non Small Cell
  232. Lung Cancer Small Cell
  233. Luprolide
  234. Lymphoma Hodgkin's, Adult
  235. Lymphoma Non-Hodgkin's, Adult
  236. M-BACOD
  237. MACOP-B
  238. MAID
  239. MCP
  240. MIME
  241. MINE/ESHAP
  242. MOPP
  243. MOPPABV Hybrid
  244. MP
  245. MPT
  246. MRC UKALL XII/ECOG E2993
  247. MVAC
  248. Main Page
  249. Malignant Mesothelioma
  250. Megestrol acetate
  251. Melanoma
  252. MiCMA
  253. Mini-BEAM
  254. Mitoxantrone + Prednisone
  255. Multiple Myeloma And Plasma Cell Dyscrasias
  256. Myelodysplastic Syndromes
  257. Nasopharyngeal Cancer
  258. Nilotinib
  259. Non-Hematological Malignancies
  260. Oblimersen + Dacarbazine
  261. Octreotide
  262. Ovarian Epithelial Cancer
  263. Oxaliplatin + Capecitabine
  264. PAC
  265. PAD
  266. PCR
  267. PCV
  268. Paclitaxel + Carboplatin + Gemcitabine
  269. Paclitaxel + Gemcitabine
  270. Paclitaxel IV + Cisplatin IP + Paclitaxel IP
  271. Pancreatic Cancer
  272. Panitumumab
  273. Pegylated liposomal doxorubicin
  274. Pemetrexed
  275. Plerixafor and G-CSF
  276. Postremission High Dose Cytarabine
  277. Prednisone
  278. Prostate Cancer
  279. R-CHOP
  280. R-CVP
  281. R-EPOCH
  282. R-FCM
  283. R-FCM + maintenance R
  284. R-GemOx
  285. R-MCP
  286. R-MPV
  287. RC
  288. RICE
  289. RTOG study 93-10
  290. Rev/Dex
  291. Rituximab, Bendamustine, Bortezomib
  292. SMILE
  293. Sandbox
  294. Sarcoma
  295. Satraplatin + Prednisone
  296. Standard3plus7
  297. Standard BEACOPP
  298. Stanford V
  299. Stem Cell Transplantation
  300. Streptozocin + 5-FU
  301. Streptozocin + Doxorubicin
  302. Sunitinib
  303. TIP
  304. Temozolomide + IFN
  305. Temozolomide + IL-2 + IFN + GM-CSF
  306. Temozolomide + RT
  307. Temozolomide + Thalidomide
  308. Temsirolimus
  309. Test spam
  310. Testicular Cancer
  311. Thal/Dex
  312. Thymoma And Thymic Carcinoma
  313. Topotecan
  314. Total Therapy 1
  315. Total Therapy 2
  316. TrophoblasticTumors, Gestational
  317. Unknown Primary, Carcinoma Of
  318. VAD
  319. VDT-PACE
  320. VIP
  321. VMP
  322. VMPT
  323. VNCOP-B
  324. VeIP
  325. Vorinostat
  326. Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel
  327. XELIRI + Bevacizumab
  328. XELOX + Bevacizumab

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)